Description: This table shows the results of an attribution of the major contributing factors to the rate of mortality improvement in cardiovascular disease between 1980 and 2000.

Description: Diabetes mellitus type 2 is an excellent model for assessing the setup of medical coverage in the U.S. health care system. It is a chronic disease that has genetic, behavioral and other medical causes, and causes many complications over the long term. From Financing Chronic Care Monograph, M-HB05-1.

Description: News release on Health Care Costs Institute and it's mission to promote research on the causes of rising U.S health spending.

Description: This SOA report describes the components of margin for calculating capitation rates in a Medicaid context along with practical issues that MCOs may face.

Description: Health Care Cost Trends 2002 - prescription drug, base and leveraged trend. From Health Section News, January 2002, Issue No. 42.

Description: This article discusses Accountable Care Organizations, how they work, managing risks and their expectations to bend the cost curve.

Description: Physicians and hospital representatives will discuss their views on health care reform, insurance companies and managed care. From Record of Society of Actuaries Vol. 20, No. 3A.

Description: This session discusses affordable health care including cost drivers, trends, the uninsured, federal funding and state initiatives. From the Record of the Society of Actuaries, Volume 29, No. 2, Session 109

Description: This session from the 2003 SOA Orlando Meeting presents various predictive models, evaluation methodologies, control groups, current and potential uses for predictive modeling and issues surrounding implementation of a predictive modeling process. From the Record of the Society of Actuaries, Volume 29, No. 3.

Description: This session describes the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. We will walk through the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. We will also walk through some sample models that illustrate how costs for emerging technologies and treatments can be modeled.